Iacono Pierluigi

Summary

Country: Italy

Publications

  1. doi request reprint Intravitreal ranibizumab versus bevacizumab for treatment of myopic choroidal neovascularization
    Pierluigi Iacono
    G B Bietti Foundation for Ophthalmology, IRCCS Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy
    Retina 32:1539-46. 2012
  2. pmc Retro-mode imaging and fundus autofluorescence with scanning laser ophthalmoscope of retinal dystrophies
    Battaglia Parodi Maurizio
    Department of Ophthalmology, Vita Salute University, San Raffaele Scientific Institute, Milan, Italy
    BMC Ophthalmol 12:8. 2012
  3. doi request reprint Intravitreal bevacizumab therapy on an as-per-needed basis in subfoveal choroidal neovascularization secondary to pathological myopia: 2-year outcomes of a prospective case series
    Pierluigi Iacono
    Fondazione G B Bietti per l Oftalmologia, Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy
    Retina 31:1841-7. 2011
  4. doi request reprint Intravitreal bevacizumab versus ranibizumab for the treatment of retinal angiomatous proliferation
    Maurizio B Parodi
    Department of Ophthalmology, University Vita Salute, Scientific Institute San Raffaele, Milano, Italy
    Acta Ophthalmol 91:267-73. 2013
  5. doi request reprint Antivascular endothelial growth factor in diabetic retinopathy
    Pierluigi Iacono
    Fondazione G B Bietti per l Oftalmologia, IRCCS Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy
    Dev Ophthalmol 46:39-53. 2010

Collaborators

Detail Information

Publications5

  1. doi request reprint Intravitreal ranibizumab versus bevacizumab for treatment of myopic choroidal neovascularization
    Pierluigi Iacono
    G B Bietti Foundation for Ophthalmology, IRCCS Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy
    Retina 32:1539-46. 2012
    ..To compare intravitreal bevacizumab (IVB) and intravitreal ranibizumab (IVR) in the treatment of subfoveal choroidal neovascularization associated with pathologic myopia...
  2. pmc Retro-mode imaging and fundus autofluorescence with scanning laser ophthalmoscope of retinal dystrophies
    Battaglia Parodi Maurizio
    Department of Ophthalmology, Vita Salute University, San Raffaele Scientific Institute, Milan, Italy
    BMC Ophthalmol 12:8. 2012
    ..The aim of the study is to analyze the contribution of retro-mode imaging (RMI) and fundus autofluorescence (FAF) to the characterization of retinal dystrophies...
  3. doi request reprint Intravitreal bevacizumab therapy on an as-per-needed basis in subfoveal choroidal neovascularization secondary to pathological myopia: 2-year outcomes of a prospective case series
    Pierluigi Iacono
    Fondazione G B Bietti per l Oftalmologia, Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy
    Retina 31:1841-7. 2011
    ..To evaluate the effects of intravitreal bevacizumab in the treatment of subfoveal choroidal neovascularization (CNV) related to pathological myopia...
  4. doi request reprint Intravitreal bevacizumab versus ranibizumab for the treatment of retinal angiomatous proliferation
    Maurizio B Parodi
    Department of Ophthalmology, University Vita Salute, Scientific Institute San Raffaele, Milano, Italy
    Acta Ophthalmol 91:267-73. 2013
    ..To evaluate the effects of intravitreal bevacizumab and ranibizumab treatments in retinal angiomatous proliferation (RAP)...
  5. doi request reprint Antivascular endothelial growth factor in diabetic retinopathy
    Pierluigi Iacono
    Fondazione G B Bietti per l Oftalmologia, IRCCS Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy
    Dev Ophthalmol 46:39-53. 2010
    ..In the current chapter, the concepts and results of anti-VEGF therapy in the treatment of the DME and PDR are presented...